Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: GATT patent extensions

Executive Summary

GATT patent extensions: Merck v. Kessler patent ruling upheld Jan. 21 when U.S. Supreme Court lets stand D.C. appeals court ruling in case. The D.C. three judge panel ruled in April that Waxman/Hatch extensions may be added to the 20-years-from-filing patent term established under the General Agreement on Tariffs & Trade if the original 17-year term of the patent was in force at the time GATT took effect on June 8, 1995. However, the panel ruled that an extension may not be added if the patent was in force due to Waxman/Hatch extensions ("The Pink Sheet" April 15, 1996, T&G-1)...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS029643

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel